ATE419859T1 - Verwendung von probiotischen bakterien zur herstellung von topischen zusammensetzungen zum schutz der haut - Google Patents

Verwendung von probiotischen bakterien zur herstellung von topischen zusammensetzungen zum schutz der haut

Info

Publication number
ATE419859T1
ATE419859T1 AT05778952T AT05778952T ATE419859T1 AT E419859 T1 ATE419859 T1 AT E419859T1 AT 05778952 T AT05778952 T AT 05778952T AT 05778952 T AT05778952 T AT 05778952T AT E419859 T1 ATE419859 T1 AT E419859T1
Authority
AT
Austria
Prior art keywords
skin
topical compositions
protect
probiotic bacteria
produce topical
Prior art date
Application number
AT05778952T
Other languages
English (en)
Inventor
Giancarla Dondi
Patrizia Malfa
Original Assignee
Proge Farm Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proge Farm Srl filed Critical Proge Farm Srl
Application granted granted Critical
Publication of ATE419859T1 publication Critical patent/ATE419859T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AT05778952T 2004-07-29 2005-07-28 Verwendung von probiotischen bakterien zur herstellung von topischen zusammensetzungen zum schutz der haut ATE419859T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT001550A ITMI20041550A1 (it) 2004-07-29 2004-07-29 Uso di batteri probiotici per la preparazione di composizioni topiche per la protezione dell'epidermide

Publications (1)

Publication Number Publication Date
ATE419859T1 true ATE419859T1 (de) 2009-01-15

Family

ID=35058737

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05778952T ATE419859T1 (de) 2004-07-29 2005-07-28 Verwendung von probiotischen bakterien zur herstellung von topischen zusammensetzungen zum schutz der haut

Country Status (7)

Country Link
EP (1) EP1778258B1 (de)
AT (1) ATE419859T1 (de)
DE (1) DE602005012276D1 (de)
ES (1) ES2320685T3 (de)
IT (1) ITMI20041550A1 (de)
PT (1) PT1778258E (de)
WO (1) WO2006013441A2 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2913337A1 (fr) * 2007-03-08 2008-09-12 Oreal Produit extemporane de soin a base d'un lyophilisat de microorganismes
CN101677583A (zh) * 2007-06-27 2010-03-24 科.汉森有限公司 用于治疗特应性皮炎的瑞士乳杆菌组合物
BRPI0916690B1 (pt) * 2008-07-29 2022-04-12 L'oreal Uso de uma quantidade eficaz de pelo menos um microorganismo probiótico, composição coméstica e/ou dermatólogica, método coméstico para tratar e/ou prevenir distúrbios estéticos do couro cabeludo em um indivíduo, processo cosmético para prevenir e/ou tratar uma condição de caspa do couro cabeludo, conjunto cosmético, e, uso cosmético de pelo menos uma quantidade eficaz de pelo menos um primeiro e um segundo agente cosmético ativo
FR2945944B1 (fr) * 2009-06-02 2011-07-15 Oreal Procede cosmetique de traitement des etats pelliculaires comprenant l'administration d'un microorganisme probiotique et d'un actif antipelliculaire
US8771669B1 (en) 2010-02-09 2014-07-08 David Gordon Bermudes Immunization and/or treatment of parasites and infectious agents by live bacteria
US9597379B1 (en) 2010-02-09 2017-03-21 David Gordon Bermudes Protease inhibitor combination with therapeutic proteins including antibodies
US8524220B1 (en) 2010-02-09 2013-09-03 David Gordon Bermudes Protease inhibitor: protease sensitivity expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteria
DE102011009798B4 (de) * 2011-01-31 2015-03-05 Merz Pharma Gmbh & Co. Kgaa Balneologische lipidhaltige probiotische Zubereitungen für kosmetische / dermatologische / medizinische Anwendungen
PL2704704T3 (pl) 2011-05-03 2019-04-30 Dupont Nutrition Biosci Aps Bakterie probiotyczne do miejscowego leczenia zaburzeń skóry
WO2013130773A2 (en) 2012-02-29 2013-09-06 Ethicon Endo-Surgery, Inc. Compositions of microbiota and methods related thereto
AU2013299605A1 (en) 2012-08-07 2015-03-26 TopGeniX, Inc. Topical composition comprising transformed bacteria expressing a compound of interest
FR2999601B1 (fr) 2012-12-17 2015-01-30 Urgo Lab Methode pour prevenir et/ou traiter les infections, colonisations ou maladies liees a staphylococcus aureus, pseudomonas aeruginosa, streptococcus pyogenes, enterococcus faecium, enterobacter cloacae, proteus mirabilis et/ou bacteroides fragilis
GR1008308B (el) 2013-05-31 2014-10-02 UNI-PHARMA ΚΛΕΩΝ ΤΣΕΤΗΣ ΦΑΡΜΑΚΕΥΤΙΚΑ ΕΡΓΑΣΤΗΡΙΑ ΑΒΕΕ με δ.τ. "UNI-PHARMA ABEE", Τοπικες φαρμακευτικες και ιατροτεχνολογικες συνθεσεις που περιεχουν συνδυασμους σουκραλφατης, υαλουρονικου οξεος, αργινινης και ενος φυσικου ενυδατικου παραγοντα
US9737592B1 (en) 2014-02-14 2017-08-22 David Gordon Bermudes Topical and orally administered protease inhibitors and bacterial vectors for the treatment of disorders and methods of treatment
JP2017519823A (ja) 2014-06-17 2017-07-20 トップジェニックス, インク.Topgenix, Inc. Ｕｖ保護用局所製剤
CA2964480A1 (en) 2014-10-31 2016-05-06 Whole Biome Inc. Methods and compositions relating to microbial treatment and diagnosis of disorders
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
EP3435765A1 (de) 2016-03-31 2019-02-06 Gojo Industries, Inc. Desinfektionszusammensetzung zur stimulation von antimikrobiellen peptiden
US10806769B2 (en) 2016-03-31 2020-10-20 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
JP2019510036A (ja) 2016-03-31 2019-04-11 ゴジョ・インダストリーズ・インコーポレイテッド プロバイオティクス／プレバイオティクス有効成分を含む清浄剤組成物
ITUA20164065A1 (it) * 2016-06-01 2017-12-01 Probiotical Spa Composizioni in gel per applicazioni topiche a base di batteri, preparazione delle stesse e loro usi.
US11564879B2 (en) 2016-11-23 2023-01-31 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
WO2019046646A1 (en) 2017-08-30 2019-03-07 Whole Biome Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS
ES3040400T3 (en) 2018-02-24 2025-10-30 Clearskin Ltd Compositions, devices, systems, kits and methods for the treatment of a skin condition
IT201800004036A1 (it) * 2018-03-28 2019-09-28 Teres Srl Gel transdermico
CA3101173A1 (en) * 2018-05-23 2019-11-28 Ko Biolabs, Inc. Lactobacillus crispatus kbl693 strain and use thereof
JP7088573B2 (ja) * 2018-05-23 2022-06-21 コバイオラブズ・インコーポレイテッド ラクトバチルス・ガッセリーｋｂｌ６９７株及びその使用
JP7811843B2 (ja) 2018-07-19 2026-02-06 ペンデュラム セラピューティクス， インコーポレイテッド 微生物生着のための方法および組成物
JP2022517754A (ja) 2019-01-04 2022-03-10 ラクトバイオ アー／エス 菌株、組成物および使用方法
IT201900000801A1 (it) * 2019-01-18 2020-07-18 Proge Farm Srl Composizione comprendente batteri probiotici non vitali e suo uso in terapia
EP3982921A1 (de) * 2019-06-13 2022-04-20 Lactobio A/S Gelzusammensetzung mit lebensfähigen mikroorganismen
FR3117340B1 (fr) * 2020-12-15 2024-01-05 Basf Beauty Care Solutions France Sas Utilisation cosmétique, nutraceutique ou dermatologique d’une souche deLactobacillus crispatus et / ou d’une composition la comprenant
EP4444333A1 (de) * 2021-12-10 2024-10-16 Biotix Pte Ltd Zusammensetzung mit lactobacillus crispratus-bakterienlysaten und/oder bakterien zur verbesserung des hautzustands

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1296148B1 (it) * 1996-11-22 1999-06-09 Renata Maria Anna Ve Cavaliere Uso di batteri lattici per accrescere il livello delle ceramidi della pelle e delle mucose, e composizioni dermatologiche e cosmetiche atte
EP1110555A1 (de) * 1999-12-22 2001-06-27 Societe Des Produits Nestle S.A. Anti-adhäsives Agens für die pathogene Hautflora

Also Published As

Publication number Publication date
WO2006013441A2 (en) 2006-02-09
PT1778258E (pt) 2009-03-31
ITMI20041550A1 (it) 2004-10-29
DE602005012276D1 (de) 2009-02-26
EP1778258A2 (de) 2007-05-02
WO2006013441A3 (en) 2006-04-06
ES2320685T3 (es) 2009-05-27
EP1778258B1 (de) 2009-01-07

Similar Documents

Publication Publication Date Title
DE602005012276D1 (de) Verwendung von probiotischen bakterien zur herstellung von topischen zusammensetzungen zum schutz der haut
EA200870019A1 (ru) Лактамовые соединения и способы их применения
MX2009000285A (es) Piperidinas sustituidas que incrementan la actividad de p53 y usos de las mismas.
EP2494059A4 (de) Verwendung von methylsulfonylmethan (msm) zur modulierung einer mikrobiellen aktivität
ATE489957T1 (de) Mittel zur behandlung von entzündlichen erkrankungen
NO20083245L (no) Sykliske antimikrobielle peptider
DE602005015451D1 (de) Auf probiotischen bakterien basierende zusammensetzung und ihre verwendung zur vorbeugung und/oder behandlung von atemwegserkrankungen und/oder infektionen sowie zur verbesserung der darmtätigkeit
MY160041A (en) Compositions and methods for treating parasitic infections
ATE506951T1 (de) Als inhibitoren von beta-secretase aktive tertiäre carbinamine mit substituierten heterocyclen zur behandlung der alzheimer- krankheit
WO2007131072A3 (en) Hydrolytically-resistant boron-containing therapeutics and methods of use
UA100840C2 (ru) Композиция для лечения вирусного гепатита
ATE526991T1 (de) Zusammensetzungen und ihre verwendungen für die gentherapeutische behandlung von knochenerkrankungen
ATE481134T1 (de) Zusammensetzungen und verwendung von tyrosinkinase-hemmern zur behandlung von pathogenen infektionen
PA8650801A1 (es) Composiciones y formulaciones de ecteinascidina, como la ecteinascidina 743
CL2008002689A1 (es) Compuestos derivados de heterociclo 1,4 piperidina sustituida; compuestos intermediarios; composicion farmaceutica; proceso de preparacion; y su uso en el tratamiento del alzheimer y esquizofrenia.
NO20073574L (no) Triazolsubstituerte aminobenzofenonforbindelser
MX2009006327A (es) Compuestos heterociclicos y metodos de uso de los mismos.
DE602004022689D1 (de) Verwendung probiotischer bakterien zur behandlung von infektionen
NO20055741D0 (no) Nye kjemiske forbindelser
TW200716091A (en) New therapeutic combinations for the treatment or prevention of psychotic disorders
ATE475651T1 (de) Aryl-substituierte heterozyklen und ihre verwendung
ATE524488T1 (de) Lysobactinamide
DE60313803D1 (de) Cathepsincysteinproteaseinhibitoren und deren verwendung zur behandlung von entzündungen und immunerkrankungen
WO2010065861A3 (en) Inhibitors of bace 1 and methods for treating alzheimer's disease
UY31131A1 (es) "oxazolidinonas sustituidas y su uso

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties